BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: de Mattos AZ, Bombassaro IZ, Vogel A, Debes JD. Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice. World J Gastroenterol 2024; 30(19): 2488-2495 [PMID: 38817660 DOI: 10.3748/wjg.v30.i19.2488]
URL: https://www.wjgnet.com/1007-9327/full/v30/i19/2488.htm
Number Citing Articles
1
Rui-Nan Zhang, Jian-Gao Fan. Lipid metabolism-related long noncoding RNAs: A potential prognostic biomarker for hepatocellular carcinomaWorld Journal of Gastroenterology 2024; 30(33): 3799-3802 doi: 10.3748/wjg.v30.i33.3799
2
Jhon E. Prieto, Diego R. Puentes, Angelo Z. Mattos, Enrique Carrera E., Javier Diaz Ferrer, Martín Padilla-Machaca, Domingo Balderramo, Manuel Mendizabal, Marco Arrese, Robin G. Prieto, Diana Torres, Marlon R. Toazza, Guilherme John Neto, Angelo A. Mattos, Cristina N. Zambrano R., Maria Grazia Venturelli Romero, Fortunato S. Principe-Meneses, Chiara Zecchin, Martin Salvatierra, Juan D. Córdoba, Daniela Moreno, Javier Eslava-Schmalbach, José D. Debes. Clinical, etiological, and demographic aspects of cirrhosis in South America: a report from the South American Liver Research NetworkAnnals of Hepatology 2026; 31(2): 102186 doi: 10.1016/j.aohep.2026.102186
3
Feng Gao, Xuefei Feng, Xinyu Li. Recent advances in polymeric nanoparticles for the treatment of hepatic diseasesFrontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1528752
4
Zhouxia Wei, Yingxian Li, Suyan Jiang. Evaluation of the efficacy of laparoscopic hepatolobectomy for primary liver cancer with early combined enteral and parenteral nutritional supportDiscover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02851-2
5
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
6
Soykan Agar. De novo Drug Design and Repurposing to Suppress Liver Cancer via VEGF-R1 Mechanism: Comprehensive Molecular Docking, Molecular Dynamics Simulations and ADME EstimationMedicinal Chemistry 2025; 21(6): 501 doi: 10.2174/0115734064333811240928105309
7
Zheng-Wen Wang, Cai-Yan Pan, Cang-Long Wei, Hui Liao, Xiao-Po Zhang, Cai-Yun Zhang, Lei Yu. Oxocrebanine inhibits the proliferation of hepatocellular carcinoma cells by promoting apoptosis and autophagyWorld Journal of Gastrointestinal Oncology 2025; 17(6): 105570 doi: 10.4251/wjgo.v17.i6.105570
8
Nguyen H. Tran, Scott A. Soefje, Nivedita Rangarajan, Purushotham Krishnappa, Tyler E. Wagner, Stephen J. Valerio, Rye Anderson, Jody C. Olson. Patient Characteristics, Treatment Patterns, and Outcomes in Unresectable Hepatocellular Carcinoma Treated with First-Line Systemic Therapy in the United StatesCancers 2025; 17(21): 3499 doi: 10.3390/cancers17213499
9
Victória Dogani Rodrigues, Cláudia Rucco Penteado Detregiachi, Manuela dos Santos Bueno, Luíza Santos de Argollo Haber, Rachel Gomes Eleutério, Eliana de Souza Bastos Mazuqueli Pereira, Virgínia Maria Cavallari Strozze Catharin, Lidiane Indiani, Vitor Cavallari Strozze Catharin, Sérgio Zabotto Dantas, Kátia Portero Sloan, Caio Sergio Galina Spilla, Lance Alan Sloan, Karina Quesada, Sandra Maria Barbalho, Lucas Fornari Laurindo. Imperatorin: A Furanocoumarin with Potential in Combating Cancer Development and Progression—A Comprehensive ReviewPharmaceuticals 2026; 19(3): 436 doi: 10.3390/ph19030436